Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Enhancing these processes involves adjusting various factors, including cell line selection, media ingredients, and bioreactor settings. A key goal is to amplify antibody yield while reducing production financial burde